Randomized Clinical Trial
Copyright ©The Author(s) 2016.
World J Clin Pediatr. Feb 8, 2016; 5(1): 118-127
Published online Feb 8, 2016. doi: 10.5409/wjcp.v5.i1.118
Table 2 Changes in “symptom related” 24 h pH monitoring indices from baseline to follow-up examination by study group
Baseline
Follow up
2-wk change
P-value(treatment x time)
Mean(SD)Mean(SD)Mean change(95%CI)
Symptom index for reflux (SI)0.0483
Formula A (n = 16)39.7-26.221.6-14.5-18.23(-31.8 to -4.57)3
Formula B (n = 15)24.5-27.219.7-20.8-5.21(-19.5 to 9.03)
Formula C (n = 16)27.7-20.633.7-24.86.49(-7.39 to 20.4)
P value (Treatment effect)0.2130.119
Symptom association probability10.096
Formula A (n = 16)87.4-25.249.5-42.5-37.93(-64.6 to -11.3)3
Formula B (n = 15)54.6-47.358.7-40.23.82(-24.1 to 31.7)
Formula C (n = 16)82.9-33.857.8-38.3-24.8(-52.0 to 2.37)
P value (Treatment effect)0.0310.762
Percentage of acid refluxes2 (%)0.067
Formula A (n = 16)39.8-26.122.6-15.0-17.23(-30.8 to -3.66)3
Formula B (n = 15)24.6-27.319.4-20.8-5.53(-19.7 to 8.65)
Formula C (n = 16)27.7-20.433.3-25.35.93(-7.89 to 19.8)
P value (Treatment effect)0.210.152
Percentage of all reflux (%)0.0143
Formula A (n = 16)47.9-22.331.0-18.1-16.93(-31.3 to -2.28)3
Formula B (n = 15)35.1-23.636.8-28.71.78(-13.3 to 16.9)
Formula C (n = 16)33.7-22.348.2-28.814.4(-0.28 to 29.2)
P value (Treatment effect)0.1670.201